Liang Dai

Jiangsu Key Laboratory Of Drug Discovery For Metabolic Disease, State Key Laboratory Of Natural Medicines
Nanjing, 210009, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Design, synthesis, and biological evaluation of aryl urea derivatives as novel STING inhibitors based on SN-011.

Design, synthesis, and biological evaluation of aryl urea derivatives as novel STING inhibitors based on SN-011.

Journal: Bioorganic & medicinal chemistry

Published: May 25, 2026

Discovery of indane and naphthalene derivatives as USP7 inhibitors.

Discovery of indane and naphthalene derivatives as USP7 inhibitors.

Journal: European journal of medicinal chemistry

Published: April 24, 2025

Design, synthesis, and Biological evaluation of novel macrocyclic derivatives as potent ATP-citrate lyase inhibitors.

Design, synthesis, and Biological evaluation of novel macrocyclic derivatives as potent ATP-citrate lyase inhibitors.

Journal: European journal of medicinal chemistry

Published: February 28, 2025

Design, synthesis, and biological evaluation of imidazolidinone derivatives as potent PPARα/δ agonists for the treatment of cholestatic liver diseases.

Design, synthesis, and biological evaluation of imidazolidinone derivatives as potent PPARα/δ agonists for the treatment of cholestatic liver diseases.

Journal: European journal of medicinal chemistry

Published: December 10, 2024

Design, synthesis, and biological evaluation of piperazine derivatives as pan-PPARs agonists for the treatment of liver fibrosis.

Design, synthesis, and biological evaluation of piperazine derivatives as pan-PPARs agonists for the treatment of liver fibrosis.

Journal: European journal of medicinal chemistry

Published: February 20, 2024

Discovery of the First Subnanomolar PPARα/δ Dual Agonist for the Treatment of Cholestatic Liver Diseases.

Discovery of the First Subnanomolar PPARα/δ Dual Agonist for the Treatment of Cholestatic Liver Diseases.

Journal: Journal of medicinal chemistry

Published: May 27, 2023

Discovery of novel AdipoRon analogues as potent anti-inflammatory agents against nonalcoholic steatohepatitis.

Discovery of novel AdipoRon analogues as potent anti-inflammatory agents against nonalcoholic steatohepatitis.

Journal: European journal of medicinal chemistry

Published: June 30, 2022

Discovery of a Novel Macrocyclic ATP Citrate Lyase Inhibitor.

Discovery of a Novel Macrocyclic ATP Citrate Lyase Inhibitor.

Journal: Journal of chemical information and modeling

Published: June 09, 2022

Particle number size distributions and formation and growth rates of different new particle formation types of a megacity in China.

Particle number size distributions and formation and growth rates of different new particle formation types of a megacity in China.

Journal: Journal of environmental sciences (China)

Published: April 19, 2022

Design, Synthesis, and Biological Evaluation of Triazolone Derivatives as Potent PPARα/δ Dual Agonists for the Treatment of Nonalcoholic Steatohepatitis.

Design, Synthesis, and Biological Evaluation of Triazolone Derivatives as Potent PPARα/δ Dual Agonists for the Treatment of Nonalcoholic Steatohepatitis.

Journal: Journal of medicinal chemistry

Published: January 21, 2022

Assessment of carbonaceous aerosols in suburban Nanjing under air pollution control measures: Insights from long-term measurements.

Assessment of carbonaceous aerosols in suburban Nanjing under air pollution control measures: Insights from long-term measurements.

Journal: Environmental research

Published: January 06, 2022

Discovery of Novel Small Molecule Inhibitors Disrupting the PCSK9-LDLR Interaction.

Discovery of Novel Small Molecule Inhibitors Disrupting the PCSK9-LDLR Interaction.

Journal: Journal of chemical information and modeling

Published: September 23, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026